
They (we) are pictured with Marcus and Jamie – ready and eager to support a mobile-enabled, cytochrome P450 measured patient of the future.
This time we covered everything from pharmacogenetics to picking up an important clinical pearl – hypothyroid induced myxedema ascites in the post-transplant setting. It’s all in scope in the name of innovation.
Until next month!
2 Comments
RT @tedeytan: Photo: #MakerDocsDC : October Edition @KPTotalHealth #CTHLive w @DentonShanks @MaloyKR & Personas https://t.co/52tCpzADS6
RT @tedeytan: Photo: #MakerDocsDC : October Edition @KPTotalHealth #CTHLive w @DentonShanks @MaloyKR & Personas https://t.co/52tCpzADS6